CardioMech Obtains Funding to Support Future In-Human Feasibility Trial for New Mitral Valve Repair Tech

CardioMech is developing a transcatheter system that it hopes could be used as an alternative to open-heart cardiac surgery to reduce or eliminate mitral regurgitation.